More broadly it is unclear why ASXL1 and ASXL2 truncation mutations can cause either loss-, or gain-of-function;21,22 or why cancers caused by BAP1 do not overlap with those caused by ASXL1/2 loss23. This evidence concerns the gene BAP1 and cancer.